Lifecome Biochemistry Co.,Ltd. (002868.SZ)
CNY 15.25
(10.03%)
CNY 15.25
(10.03%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 190.7 Million CNY | 63.21% |
| 2022 | 50.69 Million CNY | -15.93% |
| 2021 | 60.3 Million CNY | 21.19% |
| 2020 | 49.75 Million CNY | -3.18% |
| 2019 | 51.39 Million CNY | 9.26% |
| 2018 | 47.03 Million CNY | 0.88% |
| 2017 | 46.62 Million CNY | -13.02% |
| 2016 | 53.6 Million CNY | 4.61% |
| 2015 | 51.24 Million CNY | 23.12% |
| 2014 | 41.62 Million CNY | -5.6% |
| 2013 | 44.09 Million CNY | 11.86% |
| 2012 | 39.42 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 30.11 Million CNY | -16.45% |
| 2024 Q3 | 40.01 Million CNY | 99.05% |
| 2024 Q1 | 36.04 Million CNY | 10.7% |
| 2023 Q4 | 32.56 Million CNY | 84.74% |
| 2023 Q1 | 12.82 Million CNY | 65.36% |
| 2023 FY | 82.73 Million CNY | 63.21% |
| 2023 Q2 | 19.72 Million CNY | 53.72% |
| 2023 Q3 | 17.62 Million CNY | -10.62% |
| 2022 Q3 | 12.46 Million CNY | -31.37% |
| 2022 Q2 | 18.16 Million CNY | 47.73% |
| 2022 Q4 | 7.75 Million CNY | -37.78% |
| 2022 FY | 50.69 Million CNY | -15.93% |
| 2022 Q1 | 12.29 Million CNY | -30.77% |
| 2021 Q2 | 14.62 Million CNY | 13.34% |
| 2021 Q3 | 15.01 Million CNY | 2.69% |
| 2021 Q4 | 17.76 Million CNY | 18.3% |
| 2021 FY | 60.3 Million CNY | 21.19% |
| 2021 Q1 | 12.9 Million CNY | 166.69% |
| 2020 Q2 | 16.73 Million CNY | 24.95% |
| 2020 Q1 | 13.39 Million CNY | 6.79% |
| 2020 FY | 49.75 Million CNY | -3.18% |
| 2020 Q4 | 4.83 Million CNY | -67.31% |
| 2020 Q3 | 14.79 Million CNY | -11.55% |
| 2019 Q2 | 13.39 Million CNY | 27.25% |
| 2019 Q1 | 10.52 Million CNY | -32.41% |
| 2019 FY | 51.39 Million CNY | 9.26% |
| 2019 Q4 | 12.53 Million CNY | -15.99% |
| 2019 Q3 | 14.92 Million CNY | 11.39% |
| 2018 Q4 | 15.57 Million CNY | 46.75% |
| 2018 FY | 47.03 Million CNY | 0.88% |
| 2018 Q1 | 7.73 Million CNY | 17.73% |
| 2018 Q2 | 13.1 Million CNY | 69.45% |
| 2018 Q3 | 10.61 Million CNY | -19.0% |
| 2017 Q1 | 11.58 Million CNY | -24.55% |
| 2017 FY | 46.62 Million CNY | -13.02% |
| 2017 Q3 | 15.1 Million CNY | 13.01% |
| 2017 Q4 | 6.56 Million CNY | -56.51% |
| 2017 Q2 | 13.36 Million CNY | 15.39% |
| 2016 Q4 | 15.35 Million CNY | 50.24% |
| 2016 Q3 | 10.21 Million CNY | -37.54% |
| 2016 Q1 | 11.67 Million CNY | 0.0% |
| 2016 Q2 | 16.35 Million CNY | 40.09% |
| 2016 FY | 53.6 Million CNY | 4.61% |
| 2015 FY | 51.24 Million CNY | 23.12% |
| 2014 FY | 41.62 Million CNY | -5.6% |
| 2013 FY | 44.09 Million CNY | 11.86% |
| 2012 FY | 39.42 Million CNY | 0.0% |